Security Snapshot

Elevance Health, Inc. - Common Stock (ELV) Institutional Ownership

CUSIP: 036752103

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

1,529

Shares (Excl. Options)

201,572,161

Price

$350.55

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.

Create free account to save this page Review latest holder period
Type / Class
Equity / Common Stock
Symbol
ELV on NYSE
Shares outstanding
225,970,109
Price per share
$292.75
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
201,572,161
Total reported value
$70,656,206,125
% of total 13F portfolios
0.05%
Share change
+5,111,162
Value change
+$1,833,263,121
Number of holders
1,529
Price from insider filings
$292.75
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • ELV - Elevance Health, Inc. - Common Stock is tracked under CUSIP 036752103.
  • 1529 institutions reported positions in Q4 2025.
  • 1 significant owner is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 1,529 to 199 between Q4 2025 and Q1 2026.
  • Reported value moved from $70,656,206,125 to $877,158,399.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 1529 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 036752103?
CUSIP 036752103 identifies ELV - Elevance Health, Inc. - Common Stock in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of Elevance Health, Inc. - Common Stock (ELV) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 7.8% $7,319,395,282 17,694,658 BlackRock, Inc. 31 Mar 2025

As of 31 Dec 2025, 1,529 institutional investors reported holding 201,572,161 shares of Elevance Health, Inc. - Common Stock (ELV). This represents 89% of the company’s total 225,970,109 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Elevance Health, Inc. - Common Stock (ELV) together control 57% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 10% 23,019,518 +0.09% 0.12% $8,069,492,034
BlackRock, Inc. 9% 20,402,634 -0.64% 0.12% $7,152,143,257
STATE STREET CORP 4.6% 10,341,466 -0.05% 0.12% $3,625,200,906
WELLINGTON MANAGEMENT GROUP LLP 3.7% 8,289,976 +25% 0.51% $2,906,051,086
PRICE T ROWE ASSOCIATES INC /MD/ 3.3% 7,446,185 +28% 0.28% $2,610,261,000
Sanders Capital, LLC 2.5% 5,750,865 -0.31% 2.3% $2,015,965,726
GEODE CAPITAL MANAGEMENT, LLC 2.3% 5,124,599 -0.38% 0.11% $1,797,008,992
Artisan Partners Limited Partnership 2.2% 5,032,751 +10% 2.7% $1,764,230,863
HARRIS ASSOCIATES L P 2.1% 4,794,445 +50% 2.1% $1,680,692,576
First Eagle Investment Management, LLC 1.8% 4,022,874 +0.61% 2.5% $1,410,218,523
Invesco Ltd. 1.7% 3,903,878 +50% 0.21% $1,368,504,544
NORGES BANK 1.3% 3,018,586 0.11% $1,058,165,322
Grantham, Mayo, Van Otterloo & Co. LLC 1.1% 2,531,090 +0.3% 2.3% $887,274,059
MORGAN STANLEY 1.1% 2,521,123 -6.1% 0.05% $883,780,825
Bank of New York Mellon Corp 1.1% 2,408,704 +79% 0.15% $844,371,095
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 1% 2,360,858 -3.3% 0.27% $827,598,772
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 1% 2,347,771 -1.6% 0.17% $823,011,125
MANUFACTURERS LIFE INSURANCE COMPANY, THE 1% 2,275,342 +2.8% 0.66% $797,471,917
NORTHERN TRUST CORP 0.99% 2,231,428 -2% 0.1% $782,227,086
BANK OF AMERICA CORP /DE/ 0.98% 2,207,140 -15% 0.06% $773,712,932
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC 0.91% 2,051,150 +0.28% 2.2% $719,030,633
BAILLIE GIFFORD & CO 0.88% 1,977,899 -8.7% 0.58% $693,352,495
Nuveen, LLC 0.87% 1,975,317 +1.4% 0.18% $692,447,371
Legal & General Group Plc 0.83% 1,866,369 -2.9% 0.15% $654,255,655
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.77% 1,737,722 +3.1% 0.09% $609,158,447

Institutional Holders of Elevance Health, Inc. - Common Stock (ELV) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 3,004,673 $877,158,399 +$146,905,530 $292.75 199
2025 Q4 201,572,161 $70,656,206,125 +$1,833,263,121 $350.55 1,529
2025 Q3 195,581,901 $63,212,053,745 -$3,313,152,456 $323.12 1,497
2025 Q2 204,604,844 $79,498,363,022 +$1,439,627,570 $388.96 1,568
2025 Q1 200,691,838 $87,287,919,928 -$2,163,798,151 $434.96 1,638
2024 Q4 206,213,996 $75,993,957,146 -$44,680,642 $368.90 1,579
2024 Q3 204,337,175 $106,108,060,305 -$2,056,527,998 $520.00 1,677
2024 Q2 207,236,343 $112,229,086,782 +$1,221,818,434 $541.86 1,694
2024 Q1 205,794,945 $106,687,848,409 -$1,247,923,452 $518.54 1,653
2023 Q4 207,752,105 $97,963,233,994 -$247,874,299 $471.56 1,648
2023 Q3 207,903,581 $90,580,448,880 -$638,821,702 $435.42 1,517
2023 Q2 209,210,262 $92,957,672,062 -$418,252,067 $444.29 1,513
2023 Q1 210,263,353 $96,683,749,324 -$1,143,379,932 $459.81 1,505
2022 Q4 212,710,438 $109,036,688,386 -$450,450,567 $512.97 1,535
2022 Q3 213,712,340 $97,144,686,967 -$43,691,666 $454.24 1,419
2022 Q2 213,631,648 $103,081,919,033 +$244,924,540 $482.58 1,427
2022 Q1 214,741,635 $105,507,397,690 +$476,326,109 $491.22 1,405
2021 Q4 213,774,296 $99,066,091,155 -$693,430,737 $463.54 1,356
2021 Q3 215,444,748 $80,367,417,712 -$316,844,753 $372.80 1,200
2021 Q2 216,259,288 $82,538,173,898 -$202,615,221 $381.80 1,218
2021 Q1 217,018,977 $77,891,055,351 -$10,123,479 $358.95 1,197
2020 Q4 216,717,748 $69,548,509,680 -$1,210,346,982 $321.09 1,152
2020 Q3 221,726,205 $59,513,110,228 -$812,067,541 $268.59 1,069
2020 Q2 224,433,586 $58,976,107,586 +$721,554,198 $262.98 1,087
2020 Q1 221,960,038 $50,395,003,088 -$269,286,785 $227.04 1,024
2019 Q4 222,498,992 $67,185,310,864 -$895,364,531 $302.03 1,091
2019 Q3 225,668,191 $54,151,556,112 -$548,766,172 $240.10 1,000
2019 Q2 227,616,918 $64,170,095,418 +$1,536,564,497 $282.21 1,017
2019 Q1 226,368,216 $64,895,946,969 -$571,793,174 $286.98 1,060
2018 Q4 228,485,511 $59,953,636,310 +$649,953,066 $262.63 981
2018 Q3 227,218,938 $62,202,902,147 -$82,133,140 $274.05 935
2018 Q2 227,862,596 $54,180,142,736 +$475,345,916 $238.03 917
2018 Q1 226,170,388 $49,620,249,094 +$136,418,805 $219.70 914
2017 Q4 226,383,870 $50,867,636,678 -$185,837,358 $225.01 904
2017 Q3 227,037,673 $43,110,236,091 -$979,896,912 $189.88 836
2017 Q2 234,666,772 $44,173,109,626 -$691,902,449 $188.13 842
2017 Q1 237,409,781 $39,276,632,137 +$4,215,665,646 $165.38 782
2016 Q4 236,826,614 $34,047,895,479 +$101,419,844 $143.77 774
2016 Q3 233,767,626 $29,277,751,316 -$472,226,246 $125.31 720
2016 Q2 237,434,049 $31,183,934,688 +$185,770,985 $131.34 747
2016 Q1 235,568,359 $32,735,981,567 -$98,831,773 $138.99 757
2015 Q4 236,580,508 $32,994,086,121 +$245,535,016 $139.44 752
2015 Q3 234,763,359 $32,864,234,259 +$972,586,432 $140.00 747
2015 Q2 227,776,038 $37,381,525,830 -$957,364,602 $164.14 771
2015 Q1 233,007,822 $35,964,678,637 -$91,145,105 $154.41 739
2014 Q4 234,612,259 $29,496,786,731 +$29,380,309,696 $125.67 697
2014 Q3 60,821 $7,275,000 $119.61 1
2014 Q2 60,821 $6,544,000 +$615,978 $107.59 1
2014 Q1 55,096 $5,484,000 +$2,384,868 $99.54 1